异搏停为钙离子拮抗剂,主要用于抗心律失常;近年来经实验证明,对自发和诱发的逼尿肌的收缩具有强烈的抑制作用,据此我们对17例不能采用手术治疗的前列腺增生症病人试用异博停治疗,现报告如下。一、临床资料病人年龄65～78岁,平均71.5岁;病程1.5～12年,平均6.75年。肛门指诊检查,前列腺Ⅱ~0增大者13例;Ⅲ~0增大者4例。患者均系以急性尿潴留就诊,部分病人有小便淋漓的病史。都有心肺功能不全或其它一些伴发疾病。 Verapamil as a calcium antagonist, mainly for anti-arrhythmia; in recent years proved by experiments, spontaneous and induced detrusor contraction has a strong inhibitory effect, therefore, we can not be treated in 17 cases of the prostate Prophylaxis of patients with benign prostatic hyperplasia treatment, are as follows. First, the clinical data of patients aged 65 to 78 years, an average of 71.5 years of age; duration of 1.5 to 12 years, an average of 6.75 years. Anal fingering examination, prostate Ⅱ ~ 0 increased in 13 cases; Ⅲ ~ 0 increased in 4 cases. Patients were treated with acute urinary retention, some patients have a history of urine dripping. Have heart and lung insufficiency or some other associated disease.